Clinical Trials

Cartiva™ SCI MOTION Study
A Prospective, Randomized, Non-Inferiority Study to Evaluate the Effectiveness of Cartiva™ Synthetic Cartilage Implant in the Treatment of First Metatarsophalangeal Joint Osteoarthritis as
Compared to a Control.

Carticept is conducting the MOTION study to compare the effectiveness of the Cartiva™ Synthetic Cartilage Implant to an arthrodesis control in the treatment of patients with osteoarthritis of the great toe, specifically the following clinical conditions:  hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsophalangeal (MTP) joint.

This is a prospective, randomized, controlled, multicenter trial.  Patients are currently being enrolled in Canada.  Carticept plans to expand the trial in 2010 to include sites in the United Kingdom.

For additional information, patients or physicians should contact motion@carticept.com or 001-770-754-3800.